Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Weïwer

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry|July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitorsFlorence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
ACS Central Science|May 27, 2024
A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET ImagingMichael S Placzek, Daniel K Wilton, Michel Weïwer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
A foundational neuronal protein network model unifying multimodal genetic, transcriptional, and proteomic perturbations in schizophreniaGreta Pintacuda, Yu-Han H Hsu, Petra Páleníková, et al.
ACS Chemical Biology|February 28, 2018
Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic TreatmentMichel Weïwer, Qihong Xu, Jennifer P Gale, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
ACS Chemical Biology|April 30, 2016
Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional EffectsFlorence F Wagner, Joshua A Bishop, Jennifer P Gale, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry|July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitorsFlorence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
ACS Central Science|May 27, 2024
A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET ImagingMichael S Placzek, Daniel K Wilton, Michel Weïwer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
A foundational neuronal protein network model unifying multimodal genetic, transcriptional, and proteomic perturbations in schizophreniaGreta Pintacuda, Yu-Han H Hsu, Petra Páleníková, et al.
ACS Chemical Biology|February 28, 2018
Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic TreatmentMichel Weïwer, Qihong Xu, Jennifer P Gale, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
ACS Chemical Biology|April 30, 2016
Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional EffectsFlorence F Wagner, Joshua A Bishop, Jennifer P Gale, et al.
Pageof 3